Keyphrases
Alzheimer's Disease
68%
Mild Cognitive Impairment
17%
Autosomal Dominant Alzheimer's Disease
15%
Amnestic Mild Cognitive Impairment (aMCI)
13%
18F-THK5351
13%
Cortical Thickness
12%
Cortical Thinning
11%
Frontotemporal Dementia
11%
Positron Emission Tomography
9%
Amyloid Deposition
9%
Amyloid beta
9%
Cerebrospinal Fluid
9%
Korean Patients
8%
Alzheimer's Disease Pathology
8%
Symptom Onset
8%
Amyloid Status
8%
Alzheimer's Disease Classification
7%
Dementia
7%
Alzheimer's Disease Patient
7%
Sporadic Alzheimer's Disease
7%
Imaging Biomarkers
7%
Amyloid PET
7%
Standardized Uptake Value
7%
Dementia Diseases
6%
Vascular Cognitive Impairment
6%
Induced Pluripotent Stem Cells (iPSCs)
6%
Neurodegeneration
6%
Alzheimer's Disease Diagnosis
6%
Early Alzheimer's Disease
5%
Tau Pathology
5%
Amyloid Accumulation
5%
Disease Progression
5%
Brain Regions
5%
Cognitive Decline
5%
Disease Pathophysiology
5%
Mutation Carriers
5%
Disease Course
5%
Cognitive Impairment
5%
Neuroscience
Alzheimer's Disease
100%
Amyloid Protein
47%
Mild Cognitive Impairment
31%
Positron Emission Tomography
16%
Fluorine-18
16%
Positron Emission Tomography
15%
Cognitive Disorders
13%
Beta Amyloid
9%
Magnetic Resonance Imaging
9%
Magnetic Resonance Imaging
7%
Neurodegeneration
7%
Gray Matter
7%
Frontotemporal Dementia
7%
Stem Cell
6%
Parkinson's Disease
5%
Medicine and Dentistry
Alzheimer's Disease
41%
Amyloid Protein
22%
Tau
16%
Mild Cognitive Impairment
14%
Autosomal Dominant Inheritance
11%
Fluorine-18
11%
Polyethylene Terephthalate
10%
Positron Emission Tomography
10%
Biological Marker
10%
Cerebrospinal Fluid
8%
Magnetic Resonance Imaging
7%
Standardized Uptake Value
6%
Pathophysiology
5%